American International Group’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-8,613
| Closed | -$186K | – | 3004 |
|
|
2022
Q4 | $186K | Buy |
8,613
+442
| +5% | +$9.34K | ﹤0.01% | 2165 |
|
|
2022
Q3 | $158K | Buy |
8,171
+116
| +1% | +$2.4K | ﹤0.01% | 2294 |
|
|
2022
Q2 | $160K | Sell |
8,055
-322
| -4% | -$8.49K | ﹤0.01% | 2335 |
|
|
2022
Q1 | $250K | Sell |
8,377
-589
| -7% | -$17.2K | ﹤0.01% | 2110 |
|
|
2021
Q4 | $209K | Sell |
8,966
-269
| -3% | -$7.15K | ﹤0.01% | 2344 |
|
|
2021
Q3 | $288K | Sell |
9,235
-219
| -2% | -$6.78K | ﹤0.01% | 2209 |
|
|
2021
Q2 | $333 | Sell |
9,454
-418
| -4% | -$13.6K | ﹤0.01% | 2188 |
|
|
2021
Q1 | $348 | Buy |
9,872
+26
| +0.3% | +$960 | ﹤0.01% | 2040 |
|
|
2020
Q4 | $369 | Buy |
9,846
+1,893
| +24% | +$68.8K | ﹤0.01% | 1925 |
|
|
2020
Q3 | $265K | Sell |
7,953
-180
| -2% | -$5.24K | ﹤0.01% | 1967 |
|
|
2020
Q2 | $215K | Buy |
8,133
+579
| +8% | +$13.7K | ﹤0.01% | 2079 |
|
|
2020
Q1 | $124K | Buy |
7,554
+740
| +11% | +$16.3K | ﹤0.01% | 2191 |
|
|
2019
Q4 | $173K | Sell |
6,814
-57
| -0.8% | -$1.14K | ﹤0.01% | 2304 |
|
|
2019
Q3 | $137K | Buy |
6,871
+305
| +5% | +$7.89K | ﹤0.01% | 2415 |
|
|
2019
Q2 | $212K | Buy |
6,566
+758
| +13% | +$25.4K | ﹤0.01% | 2191 |
|
|
2019
Q1 | $187K | Sell |
5,808
-188
| -3% | -$5.06K | ﹤0.01% | 2247 |
|
|
2018
Q4 | $147K | Sell |
5,996
-47
| -0.8% | -$1.24K | ﹤0.01% | 2372 |
|
|
2018
Q3 | $199K | Buy |
6,043
+108
| +2% | +$3.53K | ﹤0.01% | 2422 |
|
|
2018
Q2 | $211K | Buy |
+5,935
| New | +$192K | ﹤0.01% | 2324 |
|
Other funds holding ALBO
American International Group's ALBO Position: Q1 2023 in Review
American International Group sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 8,613 shares — an estimated $186K sold.
American International Group first reported a position in ALBO in Q2 2018 and held it in 19 quarters. The position peaked at $288K in Q3 2021. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.
- American International Group reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
- American International Group sold 8,613 Albireo Pharma Inc shares in Q1 2023, an estimated $186K.
- American International Group first reported a position in Albireo Pharma Inc in Q2 2018 and held it in 19 quarters.
- American International Group's Albireo Pharma Inc position peaked at $288K in Q3 2021.
- 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.
Based on American International Group's 13F filing for Q1 2023, filed 12 May 2023.